Europe Leukapheresis Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)

No. of Pages: 132    |    Report Code: TIPRE00025790    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Leukapheresis Market

TABLE OF CONTENTS

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Europe Leukapheresis Market – By Product Type

1.3.2        Europe Leukapheresis Market – By Application

1.3.3        Europe Leukapheresis Market – By End User

1.3.4        Europe Leukapheresis Market – By Country

2.          Europe Leukapheresis Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Europe Leukapheresis Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.3        Expert Opinions

5.          Europe Leukapheresis Market – Key Market Dynamics

5.1        Market Drivers

5.1.1        Elevating Number of Voluntary Blood Donors

5.1.2        Growing Incidence of Hematologic Diseases

5.1.3        Scaling Elderly Population

5.2        Key Market Restraints

5.2.1        Heavy Cost of Leukapheresis

5.3        Key Market Opportunities

5.3.1        Boosting Opportunities in Emerging Economies

5.4        Future Trends

5.4.1        Advancements in Therapeutic Apheresis

5.5        Impact Analysis

6.          Europe Leukapheresis – Market Analysis

6.1        Europe Leukapheresis Market Revenue Forecast and Analysis

7.          Europe Leukapheresis Market Analysis – by Product Type

7.1        Overview

7.2        Europe Leukapheresis Market Share by Product Type 2021 & 2028 (%)

7.3        Leukapheresis Devices

7.3.1        Overview

7.3.2        Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          Apheresis Devices

7.3.2.1.1          Overview

7.3.2.1.2          Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.2          Leukapheresis ColuMillions and Cell Separators

7.3.2.2.1          Overview

7.3.2.2.2          Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.3          Leukoreduction Filters

7.3.2.3.1          Overview

7.3.2.3.2          Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)

7.4        Leukapheresis Disposables

7.4.1        Overview

7.4.2        Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)

8.          Europe Leukapheresis Market Analysis – by Application

8.1        Overview

8.2        Europe Leukapheresis Market Share by Application 2021 & 2028 (%)

8.3        Research Applications

8.3.1        Overview

8.3.2        Research Applications Market Revenue and Forecast to 2028 (US$ Million)

8.4        Therapeutic Applications

8.4.1        Overview

8.4.2        Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)

9.          Europe Leukapheresis Market Analysis – by End-User

9.1        Overview

9.2        Europe Leukapheresis Market Share by End-User 2021 & 2028 (%)

9.3        Pharmaceutical and Biotechnology Companies

9.3.1        Overview

9.3.2        Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)

9.4        Blood Component Providers and Blood Centers

9.4.1        Overview

9.4.2        Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)

9.5        Academic and Research Institutes

9.5.1        Overview

9.5.2        Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)

9.6        Hospitals and Transfusion Centers

9.6.1        Overview

9.6.2        Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)

10.       Europe Leukapheresis Market – Country Analysis

10.1      Overview

10.1.1     Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)

10.1.1.1       Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1       Overview

10.1.1.1.2       Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3       Germany: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.1.3.1     Germany: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.1.4       Germany: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.1.5       Germany: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.2       France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1       France: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.2.1.1     France: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.2.2       France: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.2.3       France: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.3       UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1       Overview

10.1.1.3.2       UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3       UK: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.3.3.1     UK: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.3.4       UK: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.3.5       UK: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.4       Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.1       Overview

10.1.1.4.2       Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3       Italy: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.4.3.1     Italy: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.4.4       Italy: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.4.5       Italy : Leukapheresis Market, by End User, 2019-2028 (USD Million)

10.1.1.5       Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.1       Overview

10.1.1.5.2       Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3       Spain: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.5.3.1     Spain: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.5.4       Spain: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.5.5       Spain: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.6       Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3       Rest of Europe: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.6.3.1     Rest of Europe: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.6.4       Rest of Europe: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.6.5       Rest of Europe: Leukapheresis Market, by End User, 2019–2028 (USD Million)

11.       Europe Leukapheresis Market – Impact of COVID-19 Pandemic

11.1      Impact Assessment Of COVID-19 Pandemic

12.       Europe Leukapheresis Market – Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.       Company Profiles

13.1      Asahi Kasei Corporation

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Fresenius SE & Co. KGaA

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Haemonetics Corporation

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Terumo Corporation

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      STEMCELL Technologies Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      HemaCare

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Macopharma

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      AllCells

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      STEMEXPRESS

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   BioIVT

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.       Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.            Germany: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 2.            Germany Leukapheresis Market, by D Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 3.            Germany Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.            Germany: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 5.            France: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 6.            France Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 7.            France Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.            France: Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.            UK: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 10.          UK Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 11.          UK Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12.          UK: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13.          Italy: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 14.          Italy Leukapheresis Market, by Leukapheresis Devices– Revenue and Forecast to 2028 (USD Million)

Table 15.          Italy Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          Italy: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17.          Spain: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 18.          Spain Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 19.          Spain Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 20.          Spain: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of Europe: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of Europe Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of Europe Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of Europe: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 25.          Organic Developments Done by Companies

Table 26.          Inorganic Developments Done by Companies

Table 27.          Glossary of Terms, Leukapheresis Market

LIST OF FIGURES

Figure 1.           Europe Leukapheresis Market Segmentation

Figure 2.           Europe Leukapheresis Market Segmentation, By country

Figure 3.           Europe Leukapheresis Market Overview

Figure 4.           Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market

Figure 5.           Germany to Show Significant Growth During Forecast Period

Figure 6.           Europe Leukapheresis Market, Industry Landscape

Figure 7.           Europe PEST Analysis

Figure 8.           Europe Leukapheresis market impact analysis of driver and restraints

Figure 9.           Europe Leukapheresis Market – Revenue Forecast and Analysis (2021- 2028)

Figure 10.        Europe Leukapheresis Market Share by Product Type 2021 & 2028 (%)

Figure 11.        Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Europe Leukapheresis Market Share by Application 2021 & 2028 (%)

Figure 17.        Research Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Europe Leukapheresis Market Share by End-User 2021 & 2028 (%)

Figure 20.        Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        Europe: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)

Figure 25.        Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)

Figure 26.        Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        Impact of COVID-19 Pandemic in European Country Markets

The List of Companies - Europe Leukapheresis Market

  1. Asahi Kasei Corporation                                 
  2. Fresenius SE & Co. KGaA                                
  3. Haemonetics Corporation                              
  4. Terumo Corporation                                        
  5. STEMCELL Technologies Inc.                          
  6. HemaCare  
  7. Macopharma
  8. AllCells
  9. STEMEXPRESS  
  10. BioIVT